Cargando…
How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
BACKGROUND: The World Health Organization now recommends the use of typhoid conjugate vaccines (TCVs) in typhoid-endemic countries, and Gavi, the Vaccine Alliance, added TCVs into the portfolio of subsidized vaccines. Data from the Severe Typhoid Fever in Africa (SETA) program were used to contribut...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821306/ https://www.ncbi.nlm.nih.gov/pubmed/31665772 http://dx.doi.org/10.1093/cid/ciz629 |
_version_ | 1783464120111071232 |
---|---|
author | Jeon, Hyon Jin Im, Justin Haselbeck, Andrea Holm, Marianne Rakotozandrindrainy, Raphaël Bassiahi, Abdramane Soura Panzner, Ursula Mogeni, Ondari D Seo, Hye Jin Lunguya, Octavie Jacobs, Jan Okeke, Iruka N Terferi, Mekonnen Owusu-Dabo, Ellis Dougan, Gordon Carey, Megan Steele, A Duncan Kim, Jerome H Clemens, John D Andrews, Jason R Park, Se Eun Baker, Stephen Marks, Florian |
author_facet | Jeon, Hyon Jin Im, Justin Haselbeck, Andrea Holm, Marianne Rakotozandrindrainy, Raphaël Bassiahi, Abdramane Soura Panzner, Ursula Mogeni, Ondari D Seo, Hye Jin Lunguya, Octavie Jacobs, Jan Okeke, Iruka N Terferi, Mekonnen Owusu-Dabo, Ellis Dougan, Gordon Carey, Megan Steele, A Duncan Kim, Jerome H Clemens, John D Andrews, Jason R Park, Se Eun Baker, Stephen Marks, Florian |
author_sort | Jeon, Hyon Jin |
collection | PubMed |
description | BACKGROUND: The World Health Organization now recommends the use of typhoid conjugate vaccines (TCVs) in typhoid-endemic countries, and Gavi, the Vaccine Alliance, added TCVs into the portfolio of subsidized vaccines. Data from the Severe Typhoid Fever in Africa (SETA) program were used to contribute to TCV introduction decision-making processes, exemplified for Ghana and Madagascar. METHODS: Data collected from both countries were evaluated, and barriers to and benefits of introduction scenarios are discussed. No standardized methodological framework was applied. RESULTS: The Ghanaian healthcare system differs from its Malagasy counterpart: Ghana features a functioning insurance system, antimicrobials are available nationwide, and several sites in Ghana deploy blood culture–based typhoid diagnosis. A higher incidence of antimicrobial-resistant Salmonella Typhi is reported in Ghana, which has not been identified as an issue in Madagascar. The Malagasy people have a low expectation of provided healthcare and experience frequent unavailability of medicines, resulting in limited healthcare-seeking behavior and extended consequences of untreated disease. CONCLUSIONS: For Ghana, high typhoid fever incidence coupled with spatiotemporal heterogeneity was observed. A phased TCV introduction through an initial mass campaign in high-risk areas followed by inclusion into routine national immunizations prior to expansion to other areas of the country can be considered. For Madagascar, a national mass campaign followed by routine introduction would be the introduction scenario of choice as it would protect the population, reduce transmission, and prevent an often-deadly disease in a setting characterized by lack of access to healthcare infrastructure. New, easy-to-use diagnostic tools, potentially including environmental surveillance, should be explored and improved to facilitate identification of high-risk areas. |
format | Online Article Text |
id | pubmed-6821306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68213062019-11-04 How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines? Jeon, Hyon Jin Im, Justin Haselbeck, Andrea Holm, Marianne Rakotozandrindrainy, Raphaël Bassiahi, Abdramane Soura Panzner, Ursula Mogeni, Ondari D Seo, Hye Jin Lunguya, Octavie Jacobs, Jan Okeke, Iruka N Terferi, Mekonnen Owusu-Dabo, Ellis Dougan, Gordon Carey, Megan Steele, A Duncan Kim, Jerome H Clemens, John D Andrews, Jason R Park, Se Eun Baker, Stephen Marks, Florian Clin Infect Dis Supplement Articles BACKGROUND: The World Health Organization now recommends the use of typhoid conjugate vaccines (TCVs) in typhoid-endemic countries, and Gavi, the Vaccine Alliance, added TCVs into the portfolio of subsidized vaccines. Data from the Severe Typhoid Fever in Africa (SETA) program were used to contribute to TCV introduction decision-making processes, exemplified for Ghana and Madagascar. METHODS: Data collected from both countries were evaluated, and barriers to and benefits of introduction scenarios are discussed. No standardized methodological framework was applied. RESULTS: The Ghanaian healthcare system differs from its Malagasy counterpart: Ghana features a functioning insurance system, antimicrobials are available nationwide, and several sites in Ghana deploy blood culture–based typhoid diagnosis. A higher incidence of antimicrobial-resistant Salmonella Typhi is reported in Ghana, which has not been identified as an issue in Madagascar. The Malagasy people have a low expectation of provided healthcare and experience frequent unavailability of medicines, resulting in limited healthcare-seeking behavior and extended consequences of untreated disease. CONCLUSIONS: For Ghana, high typhoid fever incidence coupled with spatiotemporal heterogeneity was observed. A phased TCV introduction through an initial mass campaign in high-risk areas followed by inclusion into routine national immunizations prior to expansion to other areas of the country can be considered. For Madagascar, a national mass campaign followed by routine introduction would be the introduction scenario of choice as it would protect the population, reduce transmission, and prevent an often-deadly disease in a setting characterized by lack of access to healthcare infrastructure. New, easy-to-use diagnostic tools, potentially including environmental surveillance, should be explored and improved to facilitate identification of high-risk areas. Oxford University Press 2019-11-15 2019-10-30 /pmc/articles/PMC6821306/ /pubmed/31665772 http://dx.doi.org/10.1093/cid/ciz629 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Articles Jeon, Hyon Jin Im, Justin Haselbeck, Andrea Holm, Marianne Rakotozandrindrainy, Raphaël Bassiahi, Abdramane Soura Panzner, Ursula Mogeni, Ondari D Seo, Hye Jin Lunguya, Octavie Jacobs, Jan Okeke, Iruka N Terferi, Mekonnen Owusu-Dabo, Ellis Dougan, Gordon Carey, Megan Steele, A Duncan Kim, Jerome H Clemens, John D Andrews, Jason R Park, Se Eun Baker, Stephen Marks, Florian How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines? |
title | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines? |
title_full | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines? |
title_fullStr | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines? |
title_full_unstemmed | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines? |
title_short | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever
in Africa Programs Contribute to the Introduction of Typhoid Conjugate
Vaccines? |
title_sort | how can the typhoid fever surveillance in africa and the severe typhoid fever
in africa programs contribute to the introduction of typhoid conjugate
vaccines? |
topic | Supplement Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821306/ https://www.ncbi.nlm.nih.gov/pubmed/31665772 http://dx.doi.org/10.1093/cid/ciz629 |
work_keys_str_mv | AT jeonhyonjin howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT imjustin howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT haselbeckandrea howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT holmmarianne howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT rakotozandrindrainyraphael howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT bassiahiabdramanesoura howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT panznerursula howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT mogeniondarid howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT seohyejin howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT lunguyaoctavie howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT jacobsjan howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT okekeirukan howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT terferimekonnen howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT owusudaboellis howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT dougangordon howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT careymegan howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT steeleaduncan howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT kimjeromeh howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT clemensjohnd howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT andrewsjasonr howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT parkseeun howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT bakerstephen howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines AT marksflorian howcanthetyphoidfeversurveillanceinafricaandtheseveretyphoidfeverinafricaprogramscontributetotheintroductionoftyphoidconjugatevaccines |